Thematic Investing Channel Coronavirus Is Having a Fleeting Interest Impact on Tech ETFs By Tom LydonApril 13, 2020
Disruptive Technology Channel Fintech ETFs Are Becoming Credible Coronavirus Plays By Tom LydonMarch 31, 2020
Disruptive Technology Channel Can the Coronavirus Actually Fuel Fintech ETFs? By Ben HernandezMarch 18, 2020
Multi-Asset Channel Look Ahead to Cybersecurity and Fintech ETFs as a Future Play By Ben HernandezMarch 10, 2020
Disruptive Technology Channel Biotech ETFs Are Not Riding the Wave from Coronavirus Panic By Max ChenJanuary 24, 2020
Beyond Basic Beta Channel Biotech ETFs Brush Off Political Attacks on Drug Prices By Tom LydonJanuary 21, 2020
Leveraged & Inverse Channel An Uncertain 2020 for Finance Sector Puts Fintech ETFs in Focus By Ben HernandezJanuary 14, 2020
Disruptive Technology Channel Disruption in Latin America Creates Opportunity for Fintech ETFs By Ben HernandezJanuary 7, 2020
Disruptive Technology Channel Don’t Leave Fintech ETFs Out of the Best New 2019 ETFs By Tom LydonDecember 20, 2019
Investing Biotech ETFs Slip as Trump Administration Pushes for Cheap Drug Imports By Max ChenDecember 18, 2019
Leveraged & Inverse Channel Consider These 2 Leveraged Biotech ETFs to Ride The M&A Trend By Ian YoungDecember 13, 2019
Innovative ETFs Channel Rising Business Investment Could Make Way for China Tech ETFs By Ben HernandezDecember 13, 2019
Thematic Investing Channel Investors Are Moving Back Into Resurgent Biotech ETFs By Tom LydonDecember 9, 2019
Innovative ETFs Channel Biotech ETFs Pop After Novartis Acquires Medicines Co. By Max ChenNovember 25, 2019
Innovative ETFs Channel QQQ Increases 32%+ YTD as Tech ETFs Enjoy Standout Year By Max ChenNovember 19, 2019